BRCA-mutation associated breast cancer and to future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for BRCA1 and BRCA2 mutations is available, BRCA mutation status can be considered when making treatment and prevention decisions for BRCA testing, BRCA mutation carriers with breast cancer. Expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.
South Asian journal of cancer. 0000 Jan [Epub]
Purvish M Parikh, J Wadhwa, S Minhas, A Gupta, S Mittal, S Ranjan, P Mehta, R Singh, S P Kataria, S Salim, M Ahmed, S Aggarwal
Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India., Department of Medical Oncology, Medanta Hospital, Gurugram, Haryana, India., Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India., Department of Radiation Oncology, Safdarjung Hospital, New Delhi, India., Department of Medical Oncology, Action Balajee Cancer Center, New Delhi, India., Department of Medicine, INHS Sanjivani, Kochi, Kerala, India., Department of Medical Oncology, Asian Institute of Medical Sciences, Faridabad, Haryana, India., Department of Medical Oncology, Artemis Hospital, Gurugram, Haryana, India., Department of Medical Oncology, Safdarjung Hospital, New Delhi, India., Department of Oncology, Hakim Sanaullah Cancer Center, Baramulla, Jammu and Kashmir, India., Department of Radiation Oncology, Jolly Grant Himalayan Institute, Dehradoon, Uttarakhand, India.